OLA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.381200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.406200E-01
Normal-vs-Stage2
6.279600E-01
Normal-vs-Stage3
8.667200E-01
Normal-vs-Stage4
4.293600E-01
Stage1-vs-Stage2
6.981200E-01
Stage1-vs-Stage3
6.849800E-01
Stage1-vs-Stage4
4.300000E-01
Stage2-vs-Stage3
4.385000E-01
Stage2-vs-Stage4
5.049400E-01
Stage3-vs-Stage4
3.239800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.448200E-01
Normal-vs-AfricanAmerican
5.971800E-01
Normal-vs-Asian
6.380000E-01
Caucasian-vs-AfricanAmerican
9.991600E-01
Caucasian-vs-Asian
8.901600E-01
AfricanAmerican-vs-Asian
9.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.045800E-01
Normal-vs-Female
6.809000E-01
Male-vs-Female
8.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.786800E-01
Normal-vs-Age(41-60Yrs)
3.861200E-01
Normal-vs-Age(61-80Yrs)
7.593200E-01
Normal-vs-Age(81-100Yrs)
4.532600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.680300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.245400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.651700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.166150E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.552000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.268200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.606800E-01
Normal-vs-Daily Drinker
9.310600E-01
Normal-vs-Weekly Drinker
6.845000E-01
Normal-vs-Occasional Drinker
1.786820E-01
Normal-vs-Social Drinker
8.185400E-01
Non Drinker-vs-Daily Drinker
8.987600E-01
Non Drinker-vs-Weekly Drinker
5.255000E-01
Non Drinker-vs-Occasional Drinker
5.879800E-02
Non Drinker-vs-Social Drinker
9.660600E-01
Daily Drinker-vs-Weekly Drinker
4.708600E-01
Daily Drinker-vs-Occasional Drinker
8.222400E-02
Daily Drinker-vs-Social Drinker
9.283800E-01
Weekly Drinker-vs-Occasional Drinker
6.759400E-01
Weekly Drinker-vs-Social Drinker
5.027400E-01
Occasional Drinker-vs-Social Drinker
3.018300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.451400E-01
Normal-vs-Grade 2
1.062450E-01
Normal-vs-Grade 3
1.197360E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.254200E-02
Grade 1-vs-Grade 3
4.042100E-02
Grade 1-vs-Grade 4
2.451400E-01
Grade 2-vs-Grade 3
9.480600E-01
Grade 2-vs-Grade 4
1.062450E-01
Grade 3-vs-Grade 4
1.197360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.043600E-01
Normal-vs-NonDiabetic
5.903400E-01
Diabetic-vs-NonDiabetic
1.608220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.573800E-01
Normal-vs-NoPancreatitis
6.260000E-01
Pancreatitis-vs-NoPancreatitis
3.712400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.466400E-01
Normal-vs-N1
6.329200E-01
N0-vs-N1
7.189800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.941200E-01
Normal-vs-TP53-NonMutant
8.842800E-01
TP53-Mutant-vs-TP53-NonMutant
3.96280000003468E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
